The treatment for Scleroderma Associated Myopathy is still largely unknown because there is not enough information about the disease. The Johns Hopkins Rheumatology Division is working to understand more about this kind of Myopathy. In this video, Dr. Julie Paik, Assistant Professor of Medicine at Johns Hopkins Rheumatology, explains the complicated nature of treating this disease.
Treatment, a healthy lifestyle, and moderate exercise are key to getting back to normal after a diagnosis of Scleroderma Associated Myopathy. In the last episode of this five-part video series, Dr. Julie Paik, Assistant Professor of Medicine at Johns Hopkins Rheumatology, explains how remission is possible in patients with this disease.
Scleroderma Associated Myopathy is a muscle disease that Scleroderma patients can develop. Unfortunately, there isn’t very much knowledge about this kind of Myopathy, but the Johns Hopkins Rheumatology Division is working to understand more about this disease. Dr. Julie Paik, Assistant Professor of Medicine at Johns Hopkins Rheumatology, explains the complicated nature of this disease.
The typical symptoms that present in Scleroderma Associated Myopathy are muscle weakness, muscle fatigue, muscle pain, muscle endurance issues, and shortness of breath because of diaphragmatic weakness and cardio involvement. Dr. Julie Paik, Assistant Professor of Medicine at Johns Hopkins Rheumatology, explains the symptoms of Scleroderma Associated Myopathy.
Scleroderma Associated Myopathy is a muscle disease that Scleroderma patients can develop. Unfortunately, there isn’t very much knowledge about this kind of Myopathy, but the Johns Hopkins Rheumatology Division is working to understand more about this disease. Dr. Julie Paik, Assistant Professor of Medicine at Johns Hopkins Rheumatology, explains the complicated nature of this disease.